Anti-proliferative therapy for HIV cure: a compound interest approach.
about
Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir.Modeling HIV persistence and cure studiesEthical issues in HIV remission trialsInsight into treatment of HIV infection from viral dynamics modelsA majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
P2860
Anti-proliferative therapy for HIV cure: a compound interest approach.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Anti-proliferative therapy for HIV cure: a compound interest approach.
@en
type
label
Anti-proliferative therapy for HIV cure: a compound interest approach.
@en
prefLabel
Anti-proliferative therapy for HIV cure: a compound interest approach.
@en
P2860
P50
P1433
P1476
Anti-proliferative therapy for HIV cure: a compound interest approach.
@en
P2093
Florian Hladik
Joshua T Schiffer
P2860
P2888
P356
10.1038/S41598-017-04160-3
P407
P577
2017-06-21T00:00:00Z
P6179
1086049921